Clinical trial
Continuous Glucose Monitoring as a Strategy to Optimize Metabolic Control in Patients With Diabetes on Peritoneal Dialysis Therapy Entitled to the IMSS
NCT06069518 is registered in ClinicalTrials.gov with Coordinación de Investigación en Salud, Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Continuous Glucose Monitoring as a Strategy to Optimize Metabolic Control in Patients With Diabetes on Peritoneal Dialysis Therapy Entitled to the IMSS
- Lead sponsor
- Coordinación de Investigación en Salud, Mexico
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 1, 2023
- Completion date
- November 1, 2024
- Enrollment
- 110 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus type 2, kidney disease, chronic, peritoneal dialysis